MedPath

The Reproductive Microbiome & Perinatal Health Outcomes

Terminated
Conditions
PreTerm Birth
Human Gastrointestinal Microbiota
Human Microbiota
Metabolomics
Interventions
Other: Survey, Sample collection
Registration Number
NCT02948192
Lead Sponsor
Baylor Research Institute
Brief Summary

Pregnant African American women between 18 and 45 years of age will be enrolled at 20 weeks of gestation or less. Biological specimens (vaginal swabs, rectal swab) will be collected at enrollment, 23-24 weeks, at 28-29 weeks, and at the onset of labor. A urine sample will be obtained at entry and at the time of delivery for metabolomic analysis. Participants will also collect a dietary survey at entry, 23-24 weeks, and 28-29 weeks. The biological specimens will then be analyzed for their microbiomial profile. This will then be correlated with the timing of their delivery as well as other comorbidities such as obesity, hypertension, and diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
55
Inclusion Criteria
  • Able to read and understand English, full decision making capabilities, African American (self-identified), Pregnant, At 20 weeks or less of gestation, Singleton pregnancy, 18-45 years of age
Exclusion Criteria
  • Race other than African American, Advanced gestational age (>20 weeks), Multiple gestations, Less than 18 years or greater than 45 years of age.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Preterm DeliverySurvey, Sample collectionAfrican american women who present for prenatal care who experience spontaneous preterm birth
Term deliverySurvey, Sample collectionAfrican american women who present for prenatal care who experience term birth
Primary Outcome Measures
NameTimeMethod
Preterm Delivery36 weeks

Onset of preterm labor with subsequent spontaneous preterm birth

Secondary Outcome Measures
NameTimeMethod
Microbiome profile36 weeks

Evaluation of characteristics of the vaginal microbiome in cohorts

Medical comorbidities36 weeks

Evaluation of the comorbidities present in the cohort

Metabolomic profile36 weeks

Evaluation of characteristics of the metabolomic products present in cohort

Term delivery36 weeks

Delivery at term

Gut Microbiome profile36 weeks

Evaluation of the characteristics of the gastrointestinal microbiome in cohorts

© Copyright 2025. All Rights Reserved by MedPath